期刊文献+

司来吉兰对帕金森病小鼠运动能力的影响 被引量:4

Effect of selegiline on athletic ability in Parkinson’s disease in mice
下载PDF
导出
摘要 目的探讨司来吉兰对帕金森病小鼠运动行为的影响。方法用MPTP诱导帕金森病小鼠模型,以脑内多巴胺神经元数目和多巴胺含量为参照,通过Open field、Cat walk实验分别考察司来吉兰对帕金森模型小鼠活动量和运动步态的影响。结果司来吉兰能增加帕金森病小鼠脑内多巴胺神经元数目和多巴胺的含量,增加帕金森病小鼠运动量,提高运动速度和平衡能力。结论司来吉兰能改善帕金森病小鼠神经行为能力。 Objective To verify the effect of selegiline on the neurological behaviors of Parkinson’s disease in mice.Methods The number of dopamine neurons and the content of dopamine as well as its metabolites in Parkinson’s disease mice induced by MPTP were tested.Open field and Cat walk assay were used to detect the movement of mice.Results Selegiline increased the number of dopamine neurons and the content of dopamine,and also increased the total ambulation time and improved Gait and postural patterns in mice with Parkinson’s disease.Conclusion Selegiline can improve the neurological behaviors of Parkinson’s disease in mice.
出处 《中南药学》 CAS 2013年第6期421-424,共4页 Central South Pharmacy
基金 科技型中小企业创新项目(No.2011J4200085) 暨南大学科研培育与创新基金(No.21613331) 国家重大新药创制-候选药物研究(No.2012ZX09103101-055) 广东省教育厅国际科技合作项目(No.gjhz1102) 广东省企业科技特派员工作站建设项目(编号:2011B090600033)
关键词 帕金森病 司来吉兰 神经行为学 多巴胺 酪氨酸羟化酶 Parkinson’s disease selegiline neurological behavior dopamine tyroxine hydroxylase
  • 相关文献

参考文献13

  • 1Cools R. Dopaminergic modulation of cognitive function-implica- tions for L-DOPA treatment in Parkinson' s disease[J]. Neurosci- ence and Biobehavioral Reviews, 2006, 30 ( 1 ) : 1-23.
  • 2Devos D, Defebvre L, Bordet R. Dopaminergic and non- dopaminergic pharmacological hypotheses for gait disorders in Parkinson' s disease[J]. Fundamental & Clinical Pharmacology, 2010, 24 (4) : 407-421.
  • 3Wadia J, Chalmers-Redman R, Ju W, et al. Mitochondrial mem- brane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by ( - )-deprenyl [J]. The Journal of Neuroscience, 1998, 18( 3 ): 932-947.
  • 4Kontkanen O, Castr6n E. Trophic effects of selegiline on cultured dopaminergic neurons [J]. Brain Research, 1999, 829 ( 1 ) : 190-192.
  • 5Steering D. DATATOP: a multicenter controlled clinical trial in early Parkinson' s disease [J]. Arch Neurol, 1989, 46 ( 10 ) : 1052-1060.
  • 6Gal S, Zheng H, Fridkin M, et al. Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunc- tional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30 [J]. Neurotoxicity Research, 2010, 17 ( 1 ) : 15-27.
  • 7Vandeputte C, Taymans JM, Casteels C, et al. Automated quan- titative gait analysis in animal models of movement disorders [J]. BMCNeuroscience, 2010, 11 (1) : 92-102.
  • 8Chuang CS, Su HL, Cheng FC, et al. Quantitative evaluation of motor function before and after engraftment of dopaminergic neu- rons in a rat model of Parkinson' s disease [J]. Journal of Biomedi- cal Science, 2010, 17 (1) : 9-18.
  • 9Vlamings R, Visser-Vandewalle V, Koopmans G, et al. High frequency stimulation of the subthalamic nucleus improves speed of locomotion but impairs forelimb movement in Parkinsonian rats [J]. Neuroscience, 2007, 148 ( 3 ) : 815-823.
  • 10Koopmans GC, Deumens R, Honig WMM, et al. The assess- ment of locomotor function in spinal cord injured rats: the impor- tance of objective analysis of coordination [J]. Journal of Neuro- trauma, 2005, 22 (2) : 214-225.

同被引文献36

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部